-
Inventure Foods Inc (NASDAQ: SNAK) shares jumped
23 percent to $4.12 after the company reported the sale of its frozen division for $50 million.
-
Akari Therapeutics PLC (ADR) (NASDAQ: AKTX)
shares 23 percent to $7.24.
-
Ballard Power Systems Inc. (USA) (NASDAQ: BLDP)
shares gained 13.6 percent to $4.21 after the company reported a collaboration with Nisshinbo Holdings to develop a Non
Precious Metal Catalyst.
-
Loxo Oncology Inc (NASDAQ: LOXO) shares jumped 13
percent to $ 84.82. Loxo Oncology announced initial LOXO-292 clinical data to be presented as late-breaking presentation at the
International Association for the Study of Lung Cancer 18th World Conference on Lung Cancer.
-
Sientra Inc (NASDAQ: SIEN) shares gained 12.6
percent to $ 14.16. William Blair upgraded Sientra from Market Perform to Outperform.
-
BiondVax Pharmaceuticals Ltd (ADR) (NASDAQ: BVXV)
shares climbed 12 percent to $7.77 after declining 11.89 percent on Tuesday.
-
eGain Corp (NASDAQ: EGAN) shares rose 11.9
percent to $2.35.
-
Aldeyra Therapeutics Inc (NASDAQ: ALDX) climbed
10.6 percent to $6.25 after surging 34.52 percent on Tuesday.
-
Emmis Communications Corporation (NASDAQ: EMMS)
shares gained 9.9 percent to $2.90.
-
Hebron Technology Co Ltd (NASDAQ: HEBT) shares
surged 9.2 percent to $3.32.
-
Dolby Laboratories, Inc. (NYSE: DLB)
gained 9.1 percent to $58.85 following news that Apple TV 4K supports Dolby vision titles.
-
Zagg Inc (NASDAQ: ZAGG) shares rose 7.4 percent
to $ 13.05. ZAGG's mophie brand announced wireless charging base compatible with new Apple iPhone 8, 8 Plus and iPhone X.
-
Centene Corp (NYSE: CNC) surged 7.2 percent to
$97.43 after the company reported the acquisition of substantially all assets of Fidelis Care for $3.75 billion.
-
Finish Line Inc (NASDAQ: FINL) shares gained 6.4
percent to $10.36. Susquehanna upgraded Finish Line from Neutral to Positive and raised the price target from $9.00 to $12.00.
-
Nordstrom, Inc. (NYSE: JWN) rose 5.4 percent to
$47.47 amid report of PE interest.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.